Cell Therapy Team Up - Thermo Fisher Scientific and UCSF launch new cell therapy manufacturing site to accelerate advanced cell therapies development

SourceThe Medicine Maker
Date Published05/22/2023
Author NameJamie Irvine

Additional Reshoring Information:

Company/Division name Thermo Fisher Scientific
Parent companyThermo Fisher Scientific
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2021
City reshored to:Mission Bay
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshoredcell therapy cGMP manufacturing
What domestic positive factors made reshoring more attractive?Eco-system synergies, Higher productivity, Manufacturing/engineering joint innovation (R&D), Skilled workforce availability/training
Find Reshoring Articles